Physician profile
Amar Parikh
NPI 1427468347
$1,358.98
in general payments reported to CMS, 2019-2025
19 companies · $21.02 in 2025
The $21.02 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57.53 · 2020: $36.21 · 2021: $710 · 2022: $418 · 2023: $63.64 · 2024: $53.07 · 2025: $21.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $137.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $359.41 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $112.18 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $107.31 | 2019-2022 | |
| Lilly USA, LLC | $98.65 | 2019-2022 | |
| Stryker Corporation | $92.47 | 2022 | |
| Pfizer INC. | $87.48 | 2020-2024 | |
| Amarin Pharma, INC. | $82.97 | 2021 | |
| Janssen Pharmaceuticals, INC | $80.39 | 2021-2022 | |
| Abbott Laboratories | $69.54 | 2022 | |
| Redhill Biopharma INC. | $58.23 | 2021-2022 | |
| Eisai INC. | $39.21 | 2024 | |
| Novartis Pharmaceuticals Corporation | $38.07 | 2021 | |
| Boston Scientific Corporation | $26.34 | 2023 | Resolution Clip |
| Biohaven Pharmaceutical Holding Company LTD. | $22.91 | 2022 | |
| Sanofi-Aventis U.S. LLC | $19.50 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $19.20 | 2021 | |
| Linus Health, INC. | $18.67 | 2023 | |
| Merck Sharp & Dohme LLC | $14.45 | 2019 | |
| Glaxosmithkline, LLC. | $12.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amar Parikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.